InCephalo
Blood & Organ Banks · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
C/o Switzerland Innovation Park Basel Ar...Website
www.incephalo.comRevenue
<$5 MillionIndustry
About InCephalo
Is InCephalo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on InCephalo recently announced quarterly report
Funding: Get notified immidiatlly once InCephalo has new funding data
Click to see if InCephalo had a recent Job posting/layoffs
Check if InCephalo has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
InCephalo, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if InCephalo is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at InCephalo
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when InCephalo launches new products
Recommended Actions
Find VP level buyers at InCephalo
Find more new buyers
Compare Similar Companies to InCephalo
Compare insights from companies similar to InCephalo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
InCephalo
Company Profile Activity
Activity Insights
InCephalo is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
InCephalo is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about InCephalo.
Top Blood & Organ Banks Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InCephalo
InCephalo Therapeutics specializes in engineering compartment-locked biologics aimed at treating glioblastoma and other central nervous system diseases. Their innovative C-Lock technology allows for localized immune activation of brain tumors while minimizing systemic exposure risks. The company is focused on developing safe and effective biologica... Read More